Kathleen Murphy

OverviewAI-generated summary

Kathleen Murphy's research program investigates the pathogenesis of oncogenic gammaherpesviruses and their role in cancer development. She has received significant federal funding from the NIH/National Cancer Institute and NIH/National Institute of Allergy and Infectious Diseases for projects focused on defining mechanisms of gammaherpesvirus-driven genomic instability in B cells, understanding KSHV LANA functions in viral pathogenesis and immune evasion, and exploring the role of lytic viral genes in oncogenic gammaherpesvirus pathogenesis. Additionally, she is a Co-PI on a grant examining how periodontal bacteria enhance oral KSHV pathogenesis and Kaposi's Sarcoma development in HIV+ patients.

Her publications reflect a broad interest in health and disease across the lifespan. Recent work includes studies on a national registry for kidney disease patients, a pilot intervention for head and neck cancer patients undergoing palliative and oncology care, and the association between early antibiotic exposure and preschool growth. She also has published on complement 3 glomerulopathy (C3G) treatment patterns and characteristics, and on respiratory distress in preterm neonates, indicating a commitment to advancing care for diverse patient populations.

Murphy's scholarship metrics include an h-index of 12, with 43 total publications and over 1,072 citations. She maintains an active lab website and collaborates with colleagues at the University of Arkansas for Medical Sciences.

Metrics

• h-index: 12
• Publications: 43
• Citations: 1,079